Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Aplastic Anemia in Thailand: Incidence and Treatment Outcome from a Prospective Nationwide Population-Based Study

Lalita Norasetthada, MD, Somchai Wongkhantee, MD, Jindaratn Chaipokam, Kanyaporn Charoenprasert, MD, Suporn Chuncharunee, MD, Ponlapat Rojnuckarin, MD PhD, Chittima Sirijerachai, MD, Wanchai Wanachiwanawin, MD, Surapol Issaragrisil, MD

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-137047

Published: 2020

Journal Articles

C3 Inhibition with Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria: Results from the Paddock and Palomino Trials

Raymond S Wong, MBChB, MD, Kalina Ignatova, Humphrey Pullon, Jameela Sathar, Pimjai Niparuck, MD, Tontanai Numbenjapon, Eric Tse, MBBS, PhD FRCP, FRCPath, Surapol Issaragrisil, MD, Eloy Roman, MD, Ismail Amine, Lisa Tan, Carl Di Casoli, Pascal Deschatelets, PhD, Cedric Francois, MD PhD, Federico Grossi, MD, Andrija Bogdanovic

Blood (2020) 136 (Supplement 1): 3–4.

https://doi.org/10.1182/blood-2020-134436

Published: 2020

Journal Articles

Long-Term Outcomes in Patients with Chronic Myeloid Leukemia in Chronic Phase Receiving Frontline Nilotinib Versus Imatinib: Enestnd 10-Year Analysis

Blood (2019) 134 (Supplement_1): 2924.

https://doi.org/10.1182/blood-2019-128761

Published: 2019

Journal Articles

Inhibition of C3 with APL-2 Results in Normalisation of Markers of Intravascular and Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Raymond SM Wong, MRCP, FRCP, Humphrey W.H. Pullon, FRACP, FRCPA, Pascal Deschatelets, PhD, Cedric G Francois, MD PhD, Mohamed Hamdani, MS, Surapol Issaragrisil, MD, Patrick Johnson, PhD, Pimjai Niparuck, MD, Tontanai Numbenjapon, MD, Jameela Sathar, MB, MRCP, MRCPath, Lisa Tan, Eric Tse, MBBS, PhD FRCP, FRCPath, Federico Grossi, MD

Blood (2018) 132 (Supplement 1): 2314.

https://doi.org/10.1182/blood-2018-99-110827

Published: 2018

Journal Articles

The Incidence of Aplastic Anemia in Thailand: Experiences from a Nationwide Registry

Wanchai Wanachiwanawin, MD, Suporn Chuncharunee, MD, Chittima Sirijerachai, MD, Ponlapat Rojnuckarin, MD PhD, Lalita Norasetthada, MD, Surapol Issaragrisil, MD FRCP, FACP, FRCPA, FRCPath

Blood (2017) 130 (Supplement 1): 4965.

https://doi.org/10.1182/blood.V130.Suppl_1.4965.4965

Published: 2017

Journal Articles

A Retrospective Multicenter Study to Evaluate the Efficacy of Rabbit Antithymocyte Globulin (rATG) Immunosuppressive Therapy As First-Line Treatment of Aplastic Anemia

Suporn Chuncharunee, MD, Raymond SM Wong, MD, Ponlapat Rojnuckarin, MD PhD, Cheng-Shyong Chang, MD, Kian Meng Chang, MD, Meng-Yao Lu, MD, Wen-Li Hwang, MD, Liang Piu Koh, MD, Tsai-Yun Chen, MD, Anskar YH Leung, MD, Lalita Norasetthada, MD, Shih-Chung Wang, MD, Ming-Chih Chang, MD, Kang-Hsi Wu, MD, Surapol Issaragrisil, MD

Blood (2015) 126 (23): 1217.

https://doi.org/10.1182/blood.V126.23.1217.1217

Published: 2015

Journal Articles

Enestnd 4-Year (y) Update: Continued Superiority of Nilotinib Vs Imatinib in Patients (pts) with Newly Diagnosed Philadelphia Chromosome–Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Hagop M. Kantarjian, MD, Dong-Wook Kim, MD, Surapol Issaragrisil, MD, Richard E Clark, Josy Reiffers, MD, Franck E. Nicolini, MD, PhD, Ricardo Pasquini, Matt Kalaycio, MD, Timothy P. Hughes, MD, MBBS, Andreas Hochhaus, MD, Charisse Kemp, Xiaolin Fan, PhD, Roger J. Waltzman, MD, Giuseppe Saglio, MD, Richard A. Larson, MD

Blood (2012) 120 (21): 1676.

https://doi.org/10.1182/blood.V120.21.1676.1676

Published: 2012

Journal Articles

Efficacy and Safety of Nilotinib In Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Patients (Pts) with Type 2 Diabetes In the ENESTnd Trial.

Giuseppe Saglio, MD, PhD, Richard A. Larson, MD, Timothy P. Hughes, MD, MBBS, Surapol Issaragrisil, MD, Anna G. Turkina, MD, PhD, David Marin, MD, FRCP, Maria Zanichelli, MD, Hirohiko Shibayama, MD, PhD, Matt E. Kalaycio, MD, Francoise Rigal-Huguet, MD, Neil J. Gallagher, MD, PhD, Marcia Kayath, MD, Ming Zheng, PhD, Hagop Kantarjian, MD, Andreas Hochhaus, MD

Blood (2010) 116 (21): 3430.

https://doi.org/10.1182/blood.V116.21.3430.3430

Published: 2010

Journal Articles

Infectious Complications in Asian Patients Treated with Alemtuzumab: Results From a Multicenter Study.

Seok Jin Kim, MD, PhD, Ary Harryanto Reksodiputro, Ann-Lii Cheng, Tanin Intragumtornchai, MD, Surapol Issaragrisil, MD, Joon Ho Moon, M.D., Jin Seok Kim, M.D., Ph.D., Je-Jung Lee, Jong Ho Won, Won Seog Kim, Yok Lam Kwong, MD

Blood (2009) 114 (22): 5009.

https://doi.org/10.1182/blood.V114.22.5009.5009

Published: 2009

Journal Articles

Nilotinib Demonstrates Superior Efficacy Compared with Imatinib in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase: Results From the International Randomized Phase III ENESTnd Trial

Giuseppe Saglio, Dong-Wook Kim, MD, PhD, Surapol Issaragrisil, MD, FRCP, FACP, FRCPA, FRCPath, Philipp D. le Coutre, MD, Josy Reiffers, MD, Clarisse Lobo, MD, Ricardo Pasquini, MD, Richard E. Clark, MD, Timothy P. Hughes, MD, MBBS, Andreas Hochhaus, MD, Neil J. Gallagher, MD, PhD, Albert Hoenekopp, MD, Mei Dong, MD, MS, Ariful Haque, MS, Hagop M. Kantarjian, MD, Richard A. Larson, MD

Blood (2009) 114 (22): LBA-1.

https://doi.org/10.1182/blood.V114.22.LBA-1.LBA-1

Published: 2009

Journal Articles

The epidemiology of aplastic anemia in Thailand

Surapol Issaragrisil, David W. Kaufman, Theresa Anderson, Kanchana Chansung, Paul E. Leaverton, Samuel Shapiro, Neal S. Young

Blood (2006) 107 (4): 1299–1307.

https://doi.org/10.1182/blood-2005-01-0161

Published: 2006

Journal Articles

Current Activities of AsiaCORD: Fast Searching System of the Qualified Cord Blod Units for Asian Patients.

Tsuneo A. Takahashi, D.Sc, Kai Hsin Lin, MD, Hoon Han, MD, Tran van Binh, MD, Nguyen Tan Binh, MD, Zhongchao Han, MD, Kai Yan Liu, MD, Surapol Issaragrisil, MD, Hideki Kodo, MD, Shigetaka Asano, MD, Dao Pei Lu, MD

Blood (2004) 104 (11): 5008.

https://doi.org/10.1182/blood.V104.11.5008.5008

Published: 2004

Journal Articles

Final Results of the Thai-NHLBI Epidemiological Study of Aplastic Anemia.

Surapol Issaragrisil, M.D., David W. Kaufman, Sc.D., Theresa E. Anderson, R.N., Kanchana Chansung, M.D., Paul Leaverton, Ph.D., Samuel Shapiro, M.B., F.R.C.P. (E.), Neal S. Young, M.D.

Blood (2004) 104 (11): 2814.

https://doi.org/10.1182/blood.V104.11.2814.2814

Published: 2004

Journal Articles

Low Drug Attributability of Aplastic Anemia in Thailand

Surapol Issaragrisil, David W. Kaufman, Theresa Anderson, Kanchana Chansung, Tharatorn Thamprasit, Jittima Sirijirachai, Anong Piankijagum, Yaowarat Porapakkham, Sathit Vannasaeng, Paul E. Leaverton, Samuel Shapiro, Neal S. Young, The Aplastic Anemia Study Group

Blood (1997) 89 (11): 4034–4039.

https://doi.org/10.1182/blood.V89.11.4034

Published: 1997

NARROW

Aplastic Anemia in Thailand: Incidence and Treatment Outcome from a Prospective Nationwide Population-Based Study

C3 Inhibition with Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria: Results from the Paddock and Palomino Trials

Long-Term Outcomes in Patients with Chronic Myeloid Leukemia in Chronic Phase Receiving Frontline Nilotinib Versus Imatinib: Enestnd 10-Year Analysis

Inhibition of C3 with APL-2 Results in Normalisation of Markers of Intravascular and Extravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

The Incidence of Aplastic Anemia in Thailand: Experiences from a Nationwide Registry

A Retrospective Multicenter Study to Evaluate the Efficacy of Rabbit Antithymocyte Globulin (rATG) Immunosuppressive Therapy As First-Line Treatment of Aplastic Anemia

Enestnd 4-Year (y) Update: Continued Superiority of Nilotinib Vs Imatinib in Patients (pts) with Newly Diagnosed Philadelphia Chromosome–Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Efficacy and Safety of Nilotinib In Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Patients (Pts) with Type 2 Diabetes In the ENESTnd Trial.

Infectious Complications in Asian Patients Treated with Alemtuzumab: Results From a Multicenter Study.

Nilotinib Demonstrates Superior Efficacy Compared with Imatinib in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase: Results From the International Randomized Phase III ENESTnd Trial

The epidemiology of aplastic anemia in Thailand

Current Activities of AsiaCORD: Fast Searching System of the Qualified Cord Blod Units for Asian Patients.

Final Results of the Thai-NHLBI Epidemiological Study of Aplastic Anemia.

Low Drug Attributability of Aplastic Anemia in Thailand

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only